UNCOVERED: Eqrx - The Untold Story

AbCellera Biologics Bets on Hot Flash Antibody as Pipeline Pivot Gains Steam

AbCellera Biologics (NASDAQ:ABCL) is emphasizing its transition from a partner-based antibody discovery business to a proprietary drug development company, Chief Financial Officer Andrew Booth said during a company presentation focused on the biotech’s pipeline and lead clinical program. Booth said

MarketBeat · Jun 4

Stocks Set to Open Higher as Investors Await Key U.S. Inflation Data and Jobs Report

September S&P 500 futures (ESU23) are up +0.18%, and September Nasdaq 100 E-Mini futures (NQU23) are up +0.26% this morning as market participants looked ahead to the release of the Fed’s favorite inflation gauge while also awaiting Friday’s nonfarm payrolls report.

Barchart · Aug 28, 2023

Benzinga's Top Ratings Upgrades, Downgrades For November 11, 2022

Upgrades

Benzinga · Nov 11, 2022